Valuation: Circio Holding ASA

Market Cap 1.96B 206M 179M 167M 153M 289M 19.59B 294M 1.97B 770M 9.77B 772M 755M 32.22B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.96B 206M 179M 167M 153M 289M 19.61B 294M 1.97B 771M 9.78B 773M 756M 32.26B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+4.73%
1 week-3.79%
Current month+5.24%
1 month+15.84%
3 months-4.11%
6 months+699.07%
Current year+641.41%
1 week 7.89
Extreme 7.89
9
1 month 7.12
Extreme 7.12
9.5
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
236.7
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap.
11/30/21 Fiscal year

Chief Executive Officer

120,000 0.1386%
5/19/21 Buy

Director

21,299 0.0246%
12/3/20 Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+5.58%-3.79%+1,294.18%-51.24% 206M
+0.05%+3.08%+38.17%+66.77% 56.7B
+0.33%-6.14%+23.32%+61.89% 51.97B
+1.84%+1.27%-14.06%-13.50% 23.33B
-0.15%-6.00%-9.42%+344.47% 21.34B
+1.27%-2.02%+32.21%-26.14% 17.44B
+9.91%-2.51%+188.84%+326.19% 14.77B
+3.83%-1.34%+47.77%+165.22% 13.84B
+1.61%+0.56%+439.92%+166.12% 12.12B
+3.14%-12.56%+59.51%+149.39% 11.14B
Average +2.66%-3.29%+210.05%+118.92% 22.28B
Weighted average by Cap. +1.51%-1.95%+58.87%+109.28%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.03M 5.24M 4.89M 4.49M 8.46M 574M 8.61M 57.65M 22.58M 286M 22.64M 22.13M 945M -45.91M -4.81M -4.18M -3.9M -3.58M -6.75M -458M -6.87M -46.01M -18.02M -229M -18.06M -17.66M -754M
Net Debt -972K -102K -88.5K -82.62K -75.85K -143K -9.71M -146K -974K -382K -4.84M -382K -374K -15.96M 2.24M 235K 204K 191K 175K 330K 22.42M 336K 2.25M 881K 11.18M 883K 864K 36.87M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
26-08-04 NOK 8.870 +7.65% 4,685,794
26-08-03 NOK 8.240 +0.49% 3,435,860
26-07-31 NOK 8.200 -3.07% 6,310,777
26-07-30 NOK 8.460 -2.20% 2,942,912
26-07-29 NOK 8.650 -3.57% 3,294,210

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock